{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:02:20Z","timestamp":1769756540975,"version":"3.49.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,15]]},"DOI":"10.2146\/ajhp140191","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T13:42:12Z","timestamp":1419946932000},"page":"121-126","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients"],"prefix":"10.1093","volume":"72","author":[{"given":"Haley G.","family":"Gibbs","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Johns Hopkins Hospital (JHH), Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Clinical, Social, and Administrative Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Shermock","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Clinical Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek A.","family":"Mirski","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"John J.","family":"Lewin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Adjunct Assistant Professor, Department of Anesthesiology and Critical Care Medicine, JHH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008205437700_b1-0720121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"15","author":"Zaccara","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t2019041008205437700_b2-0720121","first-page":"256","article-title":"Distribution of valproate to subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma in humans: a microdialysis study","volume":"42","author":"Lindberger","year":"2001","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t2019041008205437700_b3-0720121","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1445-5994.1987.tb01259.x","article-title":"Plasma concentrations of unbound valproate and the management of epilepsy","volume":"17","author":"Kilpatrick","year":"1987","journal-title":"Aust N Z J Med"},{"key":"key\n\t\t\t\t2019041008205437700_b4-0720121","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1345\/aph.1P308","article-title":"High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy","volume":"45","author":"De Matt","year":"2011","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041008205437700_b5-0720121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1345\/aph.19147","article-title":"Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia","volume":"34","author":"Haroldson","year":"2000","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041008205437700_b6-0720121","volume-title":"Depakote (divalproex sodium) package insert","author":"Abbott Laboratories","year":"2009"},{"key":"key\n\t\t\t\t2019041008205437700_b7-0720121","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","article-title":"The effect of aspirin on valproic acid metabolism","volume":"40","author":"Abbott","year":"1966","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041008205437700_b8-0720121","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041008205437700_b9-0720121","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.2042-7158.2011.01282.x","article-title":"No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy","volume":"63","author":"Suzuki","year":"2011","journal-title":"J Pharm Pharmacol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/2\/121\/28320452\/ajhp0121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T22:59:41Z","timestamp":1566169181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/2\/121\/5111621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140191","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,1,15]]},"published":{"date-parts":[[2015,1,15]]}}}